Carcinoma, Intraductal, Noninfiltrating

"Carcinoma, Intraductal, Noninfiltrating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Descriptor ID	D002285
MeSH Number(s)	C04.557.470.200.025.275 C04.557.470.200.240.187.250 C04.557.470.615.275
Concept/Terms	Carcinoma, Intraductal, Noninfiltrating Carcinoma, Intraductal, Noninfiltrating Carcinoma, Intraductal Carcinomas, Intraductal Intraductal Carcinoma Intraductal Carcinomas DCIS Ductal Carcinoma In Situ Intraductal Carcinoma, Noninfiltrating Carcinoma, Noninfiltrating Intraductal Carcinomas, Noninfiltrating Intraductal Intraductal Carcinomas, Noninfiltrating Noninfiltrating Intraductal Carcinoma Noninfiltrating Intraductal Carcinomas Atypical Ductal Hyperplasia Atypical Ductal Hyperplasia Atypical Ductal Hyperplasias Ductal Hyperplasia, Atypical Ductal Hyperplasias, Atypical Hyperplasia, Atypical Ductal Hyperplasias, Atypical Ductal

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Intraductal, Noninfiltrating".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.025.275]
Carcinoma in Situ [C04.557.470.200.240]
Breast Carcinoma In Situ [C04.557.470.200.240.187]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.240.187.250]
Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.615.275]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Intraductal, Noninfiltrating".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Intraductal, Noninfiltrating".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in this website by year, and whether "Carcinoma, Intraductal, Noninfiltrating" was a major or minor topic of these publications.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2006	1	0	1
2011	1	0	1
2012	1	1	2
2015	1	0	1
2023	1	0	1

Below are the most recent publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Profiles.

Debeljak M, Cho S, Downs BM, Considine M, Avin-McKelvey B, Wang Y, Perez PN, Grizzle WE, Hoadley KA, Lynch CF, Hernandez BY, van Diest PJ, Cozen W, Hamilton AS, Hawes D, Gabrielson E, Cimino-Mathews A, Florea LD, Cope L, Umbricht CB. Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ. Breast Cancer Res. 2024 Dec 04; 26(1):178.

View in: PubMed
Lashen A, Al-Kawaz A, Jeyapalan JN, Alqahtani S, Shoqafi A, Algethami M, Toss M, Green AR, Mongan NP, Sharma S, Akbari MR, Rakha EA, Madhusudan S. Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers. Neoplasia. 2024 01; 47:100957.

View in: PubMed
Jones V, Linebarger J, Perez S, Gabram S, Okoli J, Bumpers H, Burns B, Mosunjac M, Rizzo M. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Ann Surg Oncol. 2016 Feb; 23(2):456-64.

View in: PubMed
Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton K, Miller SM, Chhetri RK, Oldenburg AL, Fleming JM, Amos KD, Makowski L, Troester MA. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res. 2013; 15(5):R82.

View in: PubMed
Bowman E, Oprea G, Okoli J, Gundry K, Rizzo M, Gabram-Mendola S, Manne U, Smith G, Pambuccian S, Bumpers HL. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012 May-Jun; 18(3):242-7.

View in: PubMed
Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh CY, Morehead-Gee A, Gerber LH, Stout NL. Predictors of functional shoulder recovery at 1 and 12?months after breast cancer surgery. Breast Cancer Res Treat. 2012 Jul; 134(1):315-24.

View in: PubMed
Rom?n-P?rez E, Casbas-Hern?ndez P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res. 2012 Mar 19; 14(2):R51.

View in: PubMed
Conroy SM, Pagano I, Kolonel LN, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol. 2011 Oct; 35(5):448-52.

View in: PubMed
Gill JK, Maskarinec G, Pagano I, Kolonel LN. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res. 2006; 8(3):R30.

View in: PubMed

People

Explore

Similar Concepts

Top Journals